Inovio Pharmaceuticals Inc (INO)
4.065
+0.10
(+2.39%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 18:08
Inovio Pharmaceuticals Market Cap: 106.10M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 103.62M |
| November 19, 2024 | 105.18M |
| November 18, 2024 | 106.36M |
| November 15, 2024 | 111.32M |
| November 14, 2024 | 124.50M |
| November 13, 2024 | 129.20M |
| November 12, 2024 | 134.17M |
| November 11, 2024 | 139.12M |
| November 08, 2024 | 144.33M |
| November 07, 2024 | 143.81M |
| November 06, 2024 | 147.72M |
| November 05, 2024 | 146.42M |
| November 04, 2024 | 143.81M |
| November 01, 2024 | 141.99M |
| October 31, 2024 | 137.56M |
| October 30, 2024 | 144.85M |
| October 29, 2024 | 144.85M |
| October 28, 2024 | 147.72M |
| October 25, 2024 | 145.89M |
| October 24, 2024 | 147.46M |
| October 23, 2024 | 148.50M |
| October 22, 2024 | 148.50M |
| October 21, 2024 | 149.54M |
| October 18, 2024 | 146.15M |
| October 17, 2024 | 147.72M |
| Date | Value |
|---|---|
| October 16, 2024 | 149.54M |
| October 15, 2024 | 145.37M |
| October 14, 2024 | 148.50M |
| October 11, 2024 | 149.80M |
| October 10, 2024 | 140.94M |
| October 09, 2024 | 143.03M |
| October 08, 2024 | 148.24M |
| October 07, 2024 | 138.86M |
| October 04, 2024 | 144.59M |
| October 03, 2024 | 147.20M |
| October 02, 2024 | 147.46M |
| October 01, 2024 | 146.42M |
| September 30, 2024 | 150.58M |
| September 27, 2024 | 152.15M |
| September 26, 2024 | 143.06M |
| September 25, 2024 | 143.32M |
| September 24, 2024 | 154.10M |
| September 23, 2024 | 152.54M |
| September 20, 2024 | 168.25M |
| September 19, 2024 | 173.70M |
| September 18, 2024 | 175.78M |
| September 17, 2024 | 176.04M |
| September 16, 2024 | 177.08M |
| September 13, 2024 | 176.82M |
| September 12, 2024 | 172.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
95.22M
Minimum
Nov 10 2023
5.010B
Maximum
Jun 29 2020
926.08M
Average
481.51M
Median
Nov 29 2022
Market Cap Benchmarks
| Novavax Inc | 1.289B |
| Baxter International Inc | 16.84B |
| AIM ImmunoTech Inc | 13.47M |
| Protalix BioTherapeutics Inc | 122.97M |
| Armata Pharmaceuticals Inc | 75.98M |
Market Cap Related Metrics
| Price to Book Value | 1.443 |
| Price | 4.065 |
| Earnings Yield | -110.0% |